Prophylactic ciprofloxacin to prevent febrile neutropenia in adjuvant breast cancer patients receiving docetaxel (nonanthracycline) regimens.

Meena Okera,Ben W. Stevenson,Brian N. Stein,Nimit Singhal,Francis Parnis,Kerry A Cheong,Carolyn L. Bampton,Sarwan Bishnoi,Dusan Kotasek

Prophylactic ciprofloxacin to prevent febrile neutropenia in adjuvant breast cancer patients receiving docetaxel (nonanthracycline) regimens.

2014

Meena Okera
Ben W. Stevenson
Brian N. Stein
Nimit Singhal
Francis Parnis
Kerry A Cheong
Carolyn L. Bampton
Sarwan Bishnoi
Dusan Kotasek

1036 Background: Febrile neutropenia (FN) is a serious adverse effect of adjuvant chemotherapy for breast cancer. Primary GCSF prophylaxis is recommended for patients at > 20% risk of FN, but is no...

Keywords:

Breast cancer
Ciprofloxacin
Adjuvant
Febrile neutropenia
Physical therapy
Intensive care medicine
Medicine
Docetaxel
adjuvant chemotherapy
Oncology
Internal medicine
Adverse effect
Pathology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations